Page last updated: 2024-08-25

budipine and Parkinson Disease, Secondary

budipine has been researched along with Parkinson Disease, Secondary in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ceballos-Baumann, A1
Przuntek, H; Russ, H1

Reviews

1 review(s) available for budipine and Parkinson Disease, Secondary

ArticleYear
[Diagnosis and treatment of Parkinson's syndrome. What is important for the general practitioner?].
    MMW Fortschritte der Medizin, 2003, May-26, Volume: 145 Suppl 2

    Topics: Aged; Amantadine; Antiparkinson Agents; Apomorphine; Botulinum Toxins; Catechols; Cholinesterase Inhibitors; Clinical Trials as Topic; Diagnosis, Differential; Dopamine Agents; Dopamine Agonists; Enzyme Inhibitors; Ergot Alkaloids; Family Practice; Female; Humans; Levodopa; Male; Nitriles; Parkinson Disease; Parkinson Disease, Secondary; Parkinsonian Disorders; Piperidines

2003

Other Studies

1 other study(ies) available for budipine and Parkinson Disease, Secondary

ArticleYear
Budipine and the MPTP binding site.
    Lancet (London, England), 1985, Jul-06, Volume: 2, Issue:8445

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; Binding, Competitive; Humans; Parkinson Disease, Secondary; Piperidines; Pyridines; Rats; Receptors, Drug

1985